Cargando…
5-Azacytidine Suppresses the Expression of Tissue-Specific Oct-1 Isoform in Namalwa Burkitt’s Lymphoma Cell Culture
Overexpression of the transcription factor POU2F1 (Oct-1) increases the malignant potential of the tumor and determines the unfavorable prognosis for both solid and hematological cases of the disease in human carcinogenesis. The Oct-1 level determines the rate of development of the disease in acute...
Autores principales: | Kotnova, A. P., Stepchenko, A. G., Ilyin, Yu. V., Georgieva, S. G., Pankratova, E. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090699/ https://www.ncbi.nlm.nih.gov/pubmed/35538282 http://dx.doi.org/10.1134/S1607672922020089 |
Ejemplares similares
-
GSK3 Kinase Inhibitor, CHIR, Suppress Transcription of Tissue Specific POU2F1 Isoform in Burkitt Namalwa Lymphoma Cells
por: Pankratova, E. V., et al.
Publicado: (2021) -
The Emergence of a New Isoform of POU2F1 in Primates through the Use of Egoistic Mobile Genetic Elements
por: Lyanova, B. M., et al.
Publicado: (2022) -
Different N-terminal isoforms of Oct-1 control expression of distinct sets of genes and their high levels in Namalwa Burkitt's lymphoma cells affect a wide range of cellular processes
por: Pankratova, Elizaveta V., et al.
Publicado: (2016) -
The regulatory interplay between Oct-1 isoforms contributes to hematopoiesis and the isoforms imbalance correlates with a malignant transformation of B cells
por: Pankratova, Elizaveta V., et al.
Publicado: (2018) -
Suppression of OCT-1 in Metastatic Breast Cancer Cells Reduces Tumor Metastatic Potential, Hypoxia Resistance, and Drug Resistance
por: Stepchenko, Alexander G., et al.
Publicado: (2022)